News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DFine Announces Full U.S. Commercial Release of STAR Tumor Ablation System


9/18/2012 10:12:59 AM

SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced the full commercial U.S. launch of the STAR™ Tumor Ablation System. The announcement marks the nationwide release of the STAR System and percutaneous targeted Radiofrequency Ablation™ (t-RFA) therapy, which allows physicians to provide patients with rapid pain relief from metastatic spinal tumors in a single, minimally invasive treatment.

Read at BioSpace.com

comments powered by Disqus
DFine
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES